Physician profile
Ashwinkumar Joshi
NPI 1871772996
$1,708.33
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,314 · 2020: $381 · 2021: $13.87.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $406.74 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $238.59 | 2019 | |
| Allergan, INC. | $192.79 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.19 | 2019-2020 | |
| Amgen INC. | $135.41 | 2020 | |
| Novo Nordisk INC | $125.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $123.97 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.63 | 2019-2020 | |
| Glaxosmithkline, LLC. | $59.13 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.03 | 2019 | |
| Merck Sharp & Dohme LLC | $38.62 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $23.68 | 2019 | |
| Lilly USA, LLC | $23.34 | 2019 | |
| Arbor Pharmaceuticals, INC. | $22.80 | 2019 | |
| Pfizer INC. | $15.41 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashwinkumar Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.